Semler Scientific, Inc. (SMLR) stock declined over -4.87%, trading at $20.33 on NASDAQ, down from the previous close of $21.37. The stock opened at $20.33, fluctuating between $20.33 and $20.33 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 15, 2026 | 21.37 | 21.39 | 20.27 | 20.33 | 1.62M |
| Jan 14, 2026 | 19.92 | 22.53 | 19.92 | 21.37 | 786.45K |
| Jan 13, 2026 | 23.57 | 24.19 | 18.75 | 20.34 | 1.58M |
| Jan 12, 2026 | 19.69 | 22.64 | 19.50 | 22.51 | 671.65K |
| Jan 09, 2026 | 20.94 | 21.00 | 19.20 | 19.37 | 396.05K |
| Jan 08, 2026 | 20.50 | 21.17 | 19.69 | 20.67 | 463.38K |
| Jan 07, 2026 | 21.02 | 23.18 | 20.65 | 20.68 | 633.65K |
| Jan 06, 2026 | 21.53 | 22.00 | 20.18 | 21.26 | 572.95K |
| Jan 05, 2026 | 19.09 | 21.06 | 18.85 | 21.06 | 819.43K |
| Jan 02, 2026 | 15.63 | 17.95 | 15.45 | 17.78 | 538.41K |
| Dec 31, 2025 | 15.27 | 15.69 | 14.89 | 15.29 | 490.97K |
| Dec 30, 2025 | 15.57 | 16.05 | 15.18 | 15.21 | 415.07K |
| Dec 29, 2025 | 16.41 | 16.93 | 15.74 | 15.89 | 372.08K |
| Dec 26, 2025 | 17.23 | 17.48 | 16.60 | 16.70 | 174.51K |
| Dec 24, 2025 | 16.36 | 17.57 | 16.36 | 17.35 | 203.61K |
| Dec 23, 2025 | 17.01 | 17.18 | 16.29 | 16.40 | 334.19K |
| Dec 22, 2025 | 18.52 | 19.10 | 17.30 | 17.41 | 436.76K |
| Dec 19, 2025 | 17.24 | 18.16 | 17.24 | 17.93 | 553.02K |
| Dec 17, 2025 | 17.83 | 18.17 | 16.89 | 16.93 | 558.59K |
| Dec 16, 2025 | 15.93 | 17.87 | 15.93 | 17.40 | 497.19K |
Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. A flagship offering from the company is QuantaFlo, a rapid, four-minute diagnostic test performed in-office to assess blood flow. This tool allows healthcare providers to incorporate crucial blood flow measurements into their comprehensive evaluations of a patient's vascular health. Their clientele is diverse, spanning various medical specialties such as cardiology, internal medicine, nephrology, endocrinology, podiatry, and family practice. Beyond individual practitioners, Semler Scientific also serves significant healthcare organizations, including insurance plans, integrated care delivery networks, independent physician groups, and other entities that engage with the healthcare sector, such as risk assessment firms. The company distributes its products via a combination of its own sales team and a network of authorized distributors. Founded in 2007, Semler Scientific, Inc. is based in Santa Clara, California.
| Employees | 79 |
| Beta | 1.32 |
| Sales or Revenue | $68.18M |
| 5Y Sales Change% | 2.58% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep